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Cytokine interactions promote synergistic fibronectin accumulation by
mesangial cells.
Background. The development of glomerulosclerosis has been associ-
ated with the presence of the cytokines transforming growth factor-b1
(TGF-b1), tumor necrosis factor-a (TNF-a) and/or interleukin-1b (IL-
1b), at some stage in the glomerulus. To better understand the role of
these cytokines in the scarring process their effect on rat mesangial cell
fibronectin production was investigated.
Methods. Mesangial cells were exposed to 10 ng/ml of either TGF-b1,
TNF-a, or IL-1b or to TGF-b1 in combination with TNF-a or IL-1b.
Tissue culture supernatants and cell lysates were assayed for fibronectin.
Supernatants were also assayed for TGF-b1. Northern blot analyses
probing for fibronectin, transin, TIMP-1 and TGF-b1 were carried out on
RNA extracted from mesangial cells exposed to individual and combina-
tions of cytokines.
Results. Individually these cytokines were only able to induce modest
increases in fibronectin protein levels. However, when mesangial cells
were exposed to TGF-b1 in combination with either TNF-a or IL-1b then
fibronectin levels were synergistically up-regulated approximatelly fivefold
over unstimulated levels. Northern analysis demonstrated that fibronectin
mRNA levels in the combination were also synergistically increased. In
contrast, rat transin gene expression in the combinations was reduced to
well below levels induced by TNF-a and IL-1b individually. In addition,
synergistic up-regulation of both TGF-b1 protein and message by the
cytokine combinations was also observed. TGF-b1:TNF-a and TGF-b1:
IL-1b induced additive increases in TIMP-1 (tissue inhibitor of metallo-
proteinases-1) mRNA levels.
Conclusions. These data illustrate that complex interactions can occur
between cytokines within the glomerulus modulating both matrix synthetic
and degradation pathways. These could initiate the scarring process and
the development of glomerulosclerosis.
The effects of individual cytokines on the modulation of
glomerular cell proliferation, matrix synthesis and immu-
noinflammatory modulation has been extensively studied
[1, 2]. The research has usually focused on the properties
and actions of a single cytokine within any one particular
disease model.
Transforming growth factor-b (TGF-b), for example, has
been shown to play a major role in the stimulation of matrix
production by glomerular cells [3]. The level TGF-b
mRNA and the number of cells producing the protein has
been shown to be higher in glomeruli isolated from anti-
Thy-1 nephritic rats than in glomeruli from normal rats [4].
Furthermore, administration of a neutralizing antibody to
TGF-b in the same model has been shown to result in
significant suppression of extracellular matrix production
with a concomitant reduction in the degree of histological
damage [5]. Up-regulated TGF-b expression has also been
reported in other models of glomerulonephritis including
Habu snake venom-induced mesangioproliferative glomer-
ulonephritis [6], anti-glomerular basement membrane
(GBM) nephritis [7] and in puromycin aminonucleoside
nephrosis (PAN) [8]. Further support for a pathogenetic
role of TGF-b in renal scarring has been provided by the
observation that in vivo transfection of the TGF-b gene
increases the production of extracellular matrix deposition
in the kidney [9].
One potential source of this cytokine within the glomer-
ulus is the infiltrating macrophage. Ding et al demonstrated
that glomerular macrophages isolated from PAN nephrotic
or diet induced hypercholesterolemic rats expressed
TGF-b mRNA. Similarly, peritoneal macrophages from
nephrotic or diet induced hypercholesterolemic rats also
exhibited augmented TGF-b mRNA levels compared to
normal rats [10].
Macrophages are also potent sources of tumor necrosis
factor-a (TNF-a) and interleukin (IL)-1b. TNF-a has been
shown to be secreted by glomerular macrophages isolated
from rabbits with nephrotoxic nephritis [11] while anti-
TNF-a antibodies have been shown to dose dependently
reduce proteinuria and glomerular necrosis in the same
model [12]. Macrophage secretion of IL-1b has also been
demonstrated in nephrotoxic nephritis [13, 14]. In addition,
IL-1 receptor antagonist treatment has proved beneficial in
suppressing crescentic glomerulonephritis [15]. The pres-
ence of TNF-a and IL-1b has also been demonstrated
within the glomeruli of rats with acute PAN nephrosis.
Furthermore, maneuvers to reduce the macrophage infil-
trates in these animals using an EFAD diet resulted in a
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reduced number of cells staining positive for TNF-a and
IL-1b in parallel with the number of ED1 positive cells [16].
Thus, under both physiological and pathological condi-
tions mesangial cells in vivo are potentially exposed to a
number of different cytokines acting in concert at any one
time. This may be particularly pronounced in glomeruli
containing large numbers of macrophages. Support for an
important role of macrophages in the pathogenesis of
glomerulosclerosis is provided by the observations that
macrophage conditioned medium (MPCM) promotes a
series of responses in cultured mesangial cells conducive to
the initiation of the sclerotic process inducing the up-
regulation of the genes and/or proteins for fibronectin,
laminin and collagen IV, the modulators of matrix turnover
TIMP-1 and transin, and the pro-fibrogenic cytokines
TGF-b and platelet-derived growth factor (PDGF) [17].
It is unlikely that a single cytokine would act in isolation,
and thus the aim of the present study was to assess the
contribution of, and the potential interactions between,
cytokines known to be associated with the injured glomer-
ulus, in the initiation of the scarring process.
Since an increase in the magnitude and distribution of
fibronectin is the hallmark of most human and experimen-
tal models of glomerulosclerosis [18, 19], mesangial cell
production of this matrix protein was chosen as a marker of
scarring in the current study.
METHODS
Unless otherwise stated chemicals and reagents were
obtained from the Sigma Chemical Company, UK (Poole,
England, UK).
Culture of rat mesangial cells
Glomerular cells were cultured from the glomerular
explants of adult Wistar rat kidneys using standard tech-
niques [20]. The cells were cultured in RPMI 1640 supple-
mented with 20% heat-inactivated fetal calf serum (FCS),
100 U/ml penicillin (Gibco), 100 mg/ml streptomycin
(Gibco), 5 mg/ml bovine insulin and 2 mM glutamine
(Gibco). Cultured cells were characterized by their typical
stellate fusiform morphology, their positive staining for the
Thy-1 antigen [21] and their resistance to the toxic effects
of D-valine [22].
Mesangial cells of passages 2 to 10 were cultured in 24
well plates (ICN Flow) or 25 cm2 flasks (Corning), allowed
to grow to confluence and then rendered quiescent in
medium containing 0.5% FCS for 72 hours prior to use.
Culture of mesangial cells in the presence of cytokines
Confluent quiescent mesangial cells were exposed to: (a)
10 ng/ml of either platelet derived-human TGF-b1, recom-
binant murine TNF-a or recombinant murine IL-1b (R&D
Systems) or medium alone; (b) 10 ng/ml TGF-b1 in com-
bination with either 10 ng/ml TNF-a or IL-1b; (c) 10 ng/ml
of TGF-b1 in combination with 10 ng/ml TNF-a and 10
ng/ml IL-1b; (d) 10 ng/ml of either TNF-a or IL-1b in
combination with decreasing doses of TGF-b1 (10, 1, 0.1,
0.001, 0 ng/ml) for up to seven days. Mesangial cell culture
supernatants and cell lysates were assayed for fibronectin.
For Northern blot analysis confluent, quiescent mesan-
gial cells were exposed to 10 ng/ml TGF-b1, TNF-a or
IL-1b individually or in combination or to medium alone
for 24 hours.
Preparation of cell lysates
Following removal of tissue culture supernatants, cell
monolayers were washed with PBS, scraped into 1% Non-
idet P40 in wash buffer (PBS containing 0.3 M NaCl and 1%
Tween 20) and then incubated at room temperature for
approximately 30 minutes. The cell scrapings were then
transferred into 2 ml tubes and sonicated for 5 seconds and
centrifuged for 30 seconds at 11600 g. Sonication and
centifugation were repeated following which the lysate
supernatants were assayed for fibronectin and total cell
protein.
Fibronectin ELISA
Culture supernatants or cell lysates were assayed for
fibronectin using an inhibition ELISA, modified from the
method of Rennard et al [23]. Briefly, 60 ml of rat plasma
fibronectin standard (19 to 5000 ng/ml; Calbiochem, UK),
supernatant sample or cell lysate was incubated with an
equal volume of rabbit anti-rat fibronectin diluted 1:2000 in
wash buffer at 4°C overnight. Fifty microliters of this
reaction mixture was then transferred to each well of a
96-well micotiter plate (Nunc Immunoplate, Denmark)
which had been precoated at 4°C overnight with rat plasma
fibronectin (1 mg/ml in 0.05 M carbonate buffer, pH 9.6) and
blocked with 2% BSA in wash buffer for one hour at room
temperature. The plate was incubated with the reaction
mixture at room temperature for two hours. After washing
each well four times, 50 ml of goat anti-rabbit IgG conju-
gated to horseradish peroxidase (HRP; Dako) was added to
the well and incubated at room temperature for one hour.
After a further four washes 50 ml of 0.67 mg/ml 1,2
phenylenediamine dihydrochloride in 0.03 M citrate buffer
pH 5.0, containing 0.012% H2SO4 and absorbance read at
492 nm on a Titertek Multiskan Plus microtiter plate
reader (Flow Laboratories).
Transforming growth factor-b ELISA
TGF-b ELISAs were carried out using a commercially
available assay on acid activated tissue culture supernatants
according to the manufacturer’s instructions (Promega).
Protein determination
The protein content of cell lysates dissolved in 1%
Nonidet P40 was determined by a BioRad DC protein assay
using BSA standards.
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Northern blotting
Total RNA was extracted using TRIzol reagent (Gibco),
a monophasic solution of phenol and guanidinium thiocy-
anate, based on a method of Chomczynski and Sacchi [24],
according to the manufacturer’s instructions. Thirty micro-
gram aliquots of RNA were electrophoresed on a 1%
agarose gel containg 1.9% formaldehyde, in MOPS (3-[N-
morpholino]propane-sulfonic acid). The resolved RNA was
transferred on to Hybond-N nylon membranes (Amer-
sham) by capillary action using 203 SSC (1 3 SSC 5 15 mM
tri-sodium citrate, 150 mM sodium chloride). The mem-
branes were prehybridized for four hours at 37°C or 42°C
(depending on probe) with 200 mg/ml of denatured salmon
sperm DNA in 50% formamide, 1% SDS, 53 Denhardt’s,
53 SSPE (1 3 SSPE 5 11.5 mM sodium phosphate, 150 mM
sodium chloride, 1 mM EDTA). The membranes were then
hybridized overnight with a 32P-dCTP cDNA probe that
had been Klenow DNA polymerase labeled using a random
primer labeling system (Prime-a-Gene; Promega) in fresh
hybridization buffer (same composition as prehybridization
buffer). Following hybridization the membranes were
washed twice with 1% SDS, 23 SSPE at room temperature,
twice with 0.2% SDS, 0.2% SSPE at 65°C then exposed to
X-Omat LS film (Kodak) with intensifier screens at 270°C.
Membranes were subsequently stripped in boiling 5% SDS,
0.53 SSPE before reprobing. Densitometric analysis of the
transcripts was carried out on a BioRad GS 700 imaging
scanner. RNA loading was normalized using a cDNA probe
for cyclophilin.
Probes
All of the cDNA probes were generous gifts. cDNA for
rat fibronectin was from Dr. R.O. Hynes (Massachusetts
Institute of Technology, Boston, MA, USA) [25], murine
TIMP-1 cDNA was from Dr. D.T. Denhardt (Department
of Biochemistry, Rutgers University, Piscataway, NJ, USA)
[26], rat transin cDNA was from Professor R. Breathnach
(Laboratoire de Recherche, Nantes, France) [27], murine
TGF-b was from R. Akhurst (Dept. Medical Genetics,
Glasgow University, Glasgow, Scotland, UK) [28], and
human cyclophilin was from SmithKline Beecham Pharma-
ceuticals.
Statistics
To allow for variation in mesangial cell fibronectin
production between multiple experiments, the results of
the effects of cytokines or their combinations are presented
as fold increase over control (medium alone). Absolute
levels of fibronectin and TGF-b protein corrected for cell
protein concentration are also given in the text where
appropriate.
Data were expressed as means 6 SEM. For comparison of
means between two groups an unpaired t-test was used. To
compare values between multiple groups an analysis of
variance (ANOVA) with a Bonferroni correction was ap-
plied. Statistical significance was defined as P , 0.05.
RESULTS
Effect of individual cytokines on fibronectin production
Under basal conditions (no added cytokines) the fi-
bronectin concentration in mesangial cell culture superna-
tants was 132.6 6 31 ng/mg cell protein. Exposure of
mesangial cells directly to TGF-b1, TNF-a or IL-1b at 10
ng/ml resulted in small but significant increases in secreted
and cell-associated fibronectin levels (P , 0.04 vs. medium
alone, Fig. 1). For each of these cytokines, dose response
curves of up to 25 ng/ml demonstrated that 10 ng/ml of the
individual cytokine produced a maximal response (data not
shown).
Effect of combinations of cytokines on mesangial cell
fibronectin production
To assess the effects of combinations of cytokines on
fibronectin production mesangial cells were exposed to 10
ng/ml TGF-b1 added in combination with either 10 ng/ml of
TNF-a or IL-1b. This resulted in synergistic increases in
fibronectin levels to at least fivefold over unstimulated
levels (Fig. 1). Moreover, this effect was dependent on the
dose of TGF-b1; titrating TGF-b1 against constant doses of
either TNF-a or IL-1b resulted in a dose dependent
reduction in fibronectin accumulation (Fig. 2).
The combination of all three cytokines together did not
produce any greater increase in fibronectin levels compared
to that stimulated by combinations of just two cytokines
(fold increase over medium alone in secreted fibronectin of
4.19 6 1.5 vs. 4.14 6 0.65 vs. 6.4 6 2.3 for combinations of
TGF-b1:TNF-a:IL-1b vs. TGF-b1:TNF-a vs. TGF-b1:IL-
1b, respectively).
Effect of combinations of cytokines on fibronectin gene
transcription
Northern blot analysis demonstrated that individually
each cytokine induced fibronectin gene transcription above
control levels. However, a combination of TGF-b1 and
TNF-a stimulated synergistic increases in fibronectin
message to levels greater than the sum of the individual
cytokines, respectively (Fig. 3A). The TGF-b1:IL-1b
combination induced increases in fibronectin message
that ranged between additive and synergistic values (Fig.
3B).
Northern analyses probing for collagen IV (a1 chain)
and laminin (B1 chain) gene expression resulted in quali-
tatively similar results (data not shown).
Effect of cytokine combinations on the gene expression of
transin and TIMP-1
Since the observed increase in fibronectin levels in
response to cytokines could also result from decreased
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matrix degradation, Northern blot analysis was utilised to
assess the gene expression of the rat matrix metalloprotein-
ase transin and its tissue inhibitor of metalloproteinases
TIMP-1.
Individually IL-1b and TNF-a were able to up-regu-
late the gene transcription of transin over that of control.
However, unlike the effects on fibronectin gene tran-
scription, in combination with TGF-b1 transin gene
expression was reduced below levels stimulated by
TNF-a and IL-1b individually; the TGF-b1:TNF-a com-
bination reduced transin mRNA levels to 13.4 6 7.8% of
the predicted additive values of mRNA induced by
individual cytokines (P , 0.001, vs. TNF-a alone, N 5 4),
while the TGF-b1:IL-1b combination reduced expression
to 30.8 6 12.8% (P , 0.001, vs. IL-1b, N 5 4; Fig. 4 A,
B).
TIMP-1 mRNA was found to be up-regulated in re-
sponse to all cytokines, although expression was strongest
in response to IL-1b and TNF-a. In the cytokine combina-
tions expression of TIMP-1 message was equivalent to that
induced by the predicted sum of the individual cytokines
(Fig. 5 A, B).
Fig. 2. Effect of titrating TGF-b1 against a
constant dose of either TNF-a (f) or IL-1b
(u). Supernatants from cells exposed to 10, 1,
0.0, 0.01, 0.001, 0 ng/ml TGF-b1 in combination
with 10 ng/ml of either TNF-a or IL-1b were
assayed for fibronectin. Results are expressed as
the fold increase over medium alone (corrected
for cell protein) (N 5 3 each carried out in
triplicate).
Fig. 1. Effect of individual and combinations
of cytokines on fibronectin production.
Supernatants (f) and cell lysates (u) from
mesangial cells exposed to 10 ng/ml
transforming growth factor-b (TGF-b1), tumor
necrosis factor-a (TNF-a), or interleukin-1b
(IL-1b), or to 10 ng/ml TGF-b1 in combination
with 10 ng/ml of either TNF-a or IL-1b were
assayed for fibronectin. Results are expressed as
the fold increase over medium alone (corrected
for cell protein) *P , 0.04 versus medium
alone, #P , 0.001 versus individual cytokines
(N 5 5 to 22 each carried out in
quadruplicate).
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Effect of cytokine combinations on TGF-b1 mRNA and
protein
Northern analysis was performed to investigate whether
any changes in TGF-b1 expression occur in the cytokine
combinations that could possibly explain our observations.
Northern blot analysis demonstrated that both the TGF-
b1:TNF-a and TGF-b1:IL-1b combinations synergistically
up-regulated TGF-b1 message over levels induced by indi-
vidual cytokines (Fig. 6 A, B). These data were further
supported by the observation that TGF-b1 protein secre-
tion was found to be increased by the combinations over
levels induced by individual cytokines (Table 1). [Under
basal conditions (no added cytokines) the mesangial cell
supernatant contained 37.9 6 10.0 pg/mg cell protein of
TGF-b1.] When the TGF-b assays were performed on
non-activated tissue culture supernatants TGF-b1 could not
be detected (data not shown). This would suggest that the
increase in TGF-b1 in the tissue culture supernatants in
response to the cytokines was as a result of increased
endogenous production by mesangial cells and not a result
of simply measuring exogenously added TGF-b1 (which
was added in an activated state).
DISCUSSION
TGF-b, TNF-a and IL-1b have all been reported to be
present at some stage in the diseased glomerulus, and are
all known to be secreted by activated macrophages. This
study has demonstrated that individually these cytokines
have modest effects on mesangial cell fibronectin produc-
tion. However, in combination (as is likely to be found in
vivo when secreted by macrophages) they synergistically
Fig. 3. Effect of cytokine combinations on fibronectin gene transcription. Northern blot analysis of mesangial cell RNA following 24 hours of exposure
to 10 ng/ml TGF-b1, TNF-a (A) or IL-1b (B), or to TGF-b1 in combination with TNF-a (A) or IL- 1b (B). A representative blot from four experiments
is shown. Densitometric analysis incorporates data from all four experiments normalized for RNA loading and expressed as the fold increase over
control (medium alone).
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up-regulate the production of this matrix protein. Synergis-
tic interactions between bioactive peptides is not an uncom-
mon phenomenon: TNF-a has previously been shown to
synergize with interferon-g to greatly enhance fibronectin
production by human melanocytes and malignant mela-
noma cells [29]. However, this is the first report of syner-
gistic interactions between cytokines to promote extracel-
lular matrix accumulation by glomerular mesangial cells.
The increase in fibronectin levels is due, at least in part, to
an increase in message for fibronectin over and above the
levels that might be expected from an additive effect.
Whether the enhanced message is due to increased mes-
sage stability or increased rate of transcription is yet to be
investigated.
In the current study fibronectin was chosen as the marker
of the scarring process. Fibronectin itself has many prop-
erties which could further modulate the pathogenesis of
glomerulosclerosis. For example, exogenously added fi-
bronectin has been shown to modulate constitutively pro-
duced levels of cultured mesangial cell fibronectin [30, 31],
to stimulate the secretion of cytokines such as TNF-a and
IL-6 [30, 31], as well as altering certain functional charac-
teristics of mesangial cells such as phagocytosis [32]. In vivo,
circulating plasma fibronectin has been shown to specifi-
cally accumulate in end-stage renal lesions of graft versus
host disease [33], while plasma fibronectin treatment of
animals with proliferative glomerulonephritis has been
shown to decrease the amount of fibronectin in glomerular
lesions [34].
Matrix accumulation can also occur as result of a de-
crease in matrix degradation. Down regulation of specific
matrix proteinases or up-regulation of their inhibitors
Fig. 4. Effect of cytokine combinations on transin gene transcription. Northern blot analysis of mesangial cell RNA following exposure to 10 ng/ml
TGF-b1, TNF-a (A) or IL-1b (B) or to TGF-b1 in combination with TNF-a (A) or IL-1b (B). A representative blot from four experiments is shown.
Densitometric analysis incorporates data from all four experiments normalized for RNA loading and expressed as the fold increase over control.
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would also be expected to result in an accumulation of
matrix. In the current study the gene expression of the
matrix metalloproteinase transin was markedly reduced by
the cytokine combinations compared to the mRNA levels
induced by TNF-a or IL-1b individually. These data sug-
gest that TGF-b1 in the combination inhibits the transcrip-
tion of transin induced by either TNF-a or IL-1b possibly
by inhibiting transin gene expression via an upstream
sequence in the transin promoter called the TGF-b-inhib-
itory element [35]. TGF-b is one example of a factor that
regulates the induction of TIMP-1 and the protease transin
in opposite directions, the net effect of which is to inhibit
the degradation of matrix. TGF-b is known to be a potent
stimulator of the synthesis of matrix components exerting
dual effects on matrix accumulation. However, TGF-b
alone, in this study, did not cause the marked increases in
fibronectin by rat mesangial cells that were induced by the
cytokine combinations. This may possibly be explained by
the fact that the cytokine combinations also up-regulated
the production of TGF-b1 mRNA and endogenous TGF-b1
protein by mesangial cells. This would be expected to result
in a further suppression of the transin gene and hence
fibronectin accumulation as a result of decreased degrada-
tion.
Taken together, these data suggest that accumulation of
fibronectin in response to cytokine combinations occurs as
a result of the combined effects of increased fibronectin
synthesis and decreased matrix degradation, the latter
occurring as a result of a decrease in transin expression and
an additive increase in TIMP-1 expression. A contribution
from a degree of post-translational modification of protein
expression cannot be excluded at this stage.
The observations in this study also illustrate the pitfalls in
looking at one cytokine in isolation in a biological system.
Fig. 5. Effect of cytokine combinations on TIMP-1 gene transcription. Northern blot analysis of mesangial RNA following exposure to 10 ng/ml
TGF-b1, TNF-a (A) or IL-1b (B) or to TGF-b1 in combination with TNF-b (A) or IL-1b (B). A representative blot from four experiments is shown.
Densitometric analysis incorporates data from all four experiments normalized for RNA loading and expressed as the fold increase over control.
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Such an approach will miss potentially important interac-
tions with other cytokines or the effects of one cytokine
could be misinterpreted. The role of cytokines in disease is
contextual and depends on a wide variety of factors includ-
ing the presence of other growth factors, cytokines and
hormones, which can act both synergistically and antago-
nistically with respect to one another, and on cell type and
environment. Alterations in the local cytokine network,
such as would be experienced during a macrophage influx,
are crucial. Alterations in cytokine secretion could change
the nature of cytokine interactions within the local environ-
ment of the resident glomerular cells and ultimately per-
turb the fine balance between matrix synthesis and degra-
dation. This would in turn alter the morphology and
functions of these cells within the glomerulus.
In conclusion, these data suggest one way cytokines may
interact with each other within the glomerulus to initiate
the scarring process.
Fig. 6. Effect of cytokine combinations on TGF-b1 gene transcription. Northern blot analysis of mesangial cell RNA following 24 hours of exposure
to 10 ng/ml TGF-b1, TNF-a (A) or IL-1b (B) or to TGF-b1 in combination with TNF-a (A) or IL-1b (B). A representative blot from four experiments
is shown. Densitometric analysis incorporates data from all four experiments normalized for RNA loading and expressed as the fold increase over
control.
Table 1. Mesangial cells were exposed to 10 ng/ml TGF-b1, TNF-a or IL-1b, or to TGF-b1 in combination with TNF-a or IL-1b
Cytokines TGF-b TNF-a IL-1b TGF-b 1 TNF-a TGF-b 1 IL-1b Medium
Fold increase over control 1.77 6 0.2 1.24 6 0.2 1.88 6 0.7 3.13 6 0.5 2.87 6 0.65 1.0
Tissue culture supernatants were assayed for TGF-b1. Results are expressed as the fold increase in TGF-b over medium alone after correction for
cell protein (N 5 3).
Abbreviations are: TGF, transforming growth factor; TNF, tumor necrosis factor; IL- interleukin.
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